How does Pyridostigmine differ from Neostigmine?

Pyridostigmine differs from Neostigmine primarily in terms of its duration of action. Pyridostigmine is known for having a longer duration of effect compared to Neostigmine, which makes it more suitable for chronic management conditions, such as myasthenia gravis. This longer duration allows for a more sustained therapeutic effect, helping to alleviate symptoms throughout the day without the need for frequent dosing.

While Neostigmine is effective, it typically has a shorter duration of action, often necessitating more frequent administration to maintain symptom control. Consequently, in clinical practice, Pyridostigmine is often favored for ongoing treatment of chronic conditions, while Neostigmine may be utilized in situations requiring shorter-term intervention.